🇺🇸 FDA
Patent

US 6310088

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

expired A61PA61P1/02A61P1/14

Quick answer

US patent 6310088 (Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity) held by Darwin Discovery Limited expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Darwin Discovery Limited
Grant date
Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
60
CPC classes
A61P, A61P1/02, A61P1/14, A61P17/00, A61P25/06